BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 26704433)

  • 1. A case study on the potential angiogenic effect of human chorionic gonadotropin hormone in rapid progression and spontaneous regression of metastatic renal cell carcinoma during pregnancy and after surgical abortion.
    Mangel L; Bíró K; Battyáni I; Göcze P; Tornóczky T; Kálmán E
    BMC Cancer; 2015 Dec; 15():1013. PubMed ID: 26704433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Spontaneous regression of pulmonary metastases in renal cancer].
    Rauh S; Duhem C; Ries F; Dicato M; Lamy S; Lens V
    Bull Soc Sci Med Grand Duche Luxemb; 1998; 135(1):39-42. PubMed ID: 9868831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Xp11.2 translocation renal carcinoma with placental metastasis: a case report.
    Bovio IM; Allan RW; Oliai BR; Hampton T; Rush DS
    Int J Surg Pathol; 2011 Feb; 19(1):80-3. PubMed ID: 19164407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of anti-angiogenic treatments on metastatic renal cell carcinoma.
    Ainsworth NL; Lee JS; Eisen T
    Expert Rev Anticancer Ther; 2009 Dec; 9(12):1793-805. PubMed ID: 19954291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spontaneous regression of pleural metastases after nephrectomy for renal cell carcinoma--a histologically verified case with nine-year follow-up.
    Thoroddsen A; Gudbjartsson T; Geirsson G; Agnarsson BA; Magnusson K
    Scand J Urol Nephrol; 2002; 36(5):396-8. PubMed ID: 12487751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Luteinizing hormone receptor status and clinical, pathologic, and prognostic features in patients with breast carcinomas.
    Meduri G; Charnaux N; Spyratos F; Hacene K; Loosfelt H; Milgrom E
    Cancer; 2003 Apr; 97(7):1810-6. PubMed ID: 12655539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The problematic nature of metastasized renal cell carcinoma.
    Bichler KH; Wechsel HW
    Anticancer Res; 1999; 19(2C):1463-6. PubMed ID: 10365124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence and Clinical Relevance of Tumor Flare in Patients Who Discontinue Tyrosine Kinase Inhibitors for Treatment of Metastatic Renal Cell Carcinoma.
    Iacovelli R; Massari F; Albiges L; Loriot Y; Massard C; Fizazi K; Escudier B
    Eur Urol; 2015 Jul; 68(1):154-60. PubMed ID: 25466943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endostatin- and interleukin-2-expressing retroviral bicistronic vector for gene therapy of metastatic renal cell carcinoma.
    Rocha FG; Calvo FB; Chaves KC; Peron JP; Marques RF; de Borba TR; Braga MS; Pereira CB; Vicente EJ; Chammas R; Schor N; Bellini MH
    J Gene Med; 2011 Mar; 13(3):148-57. PubMed ID: 21344541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of everolimus for second-line treatment of metastatic renal cell carcinoma in Serbia.
    Mihajlović J; Pechlivanoglou P; Sabo A; Tomić Z; Postma MJ
    Clin Ther; 2013 Dec; 35(12):1909-22. PubMed ID: 24238790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumour burden is an independent prognostic factor in metastatic renal cell carcinoma.
    Iacovelli R; Lanoy E; Albiges L; Escudier B
    BJU Int; 2012 Dec; 110(11):1747-53. PubMed ID: 23106948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sarcomatoid renal cell carcinoma with a chromophobe component producing beta-human chorionic gonadotropin.
    Shimomura T; Ikemoto I; Yamada H; Hayashi N; Ito H; Oishi Y
    Int J Urol; 2005 Sep; 12(9):835-7. PubMed ID: 16201981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination or sequencing strategies to improve the outcome of metastatic renal cell carcinoma patients: a critical review.
    Porta C; Szczylik C; Escudier B
    Crit Rev Oncol Hematol; 2012 Jun; 82(3):323-37. PubMed ID: 21733715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human chorionic gonadotropin inhibits N-Methyl-N-nitrosourea-induced mammary carcinoma growth in female Lewis rats.
    Yuri T; Lai YC; Yoshizawa K; Tsubura A
    In Vivo; 2012; 26(3):361-7. PubMed ID: 22523287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic factors for cases with metastatic renal cell carcinoma in the era of targeted medicine.
    Neuzillet Y; Culine S; Patard JJ
    Int J Urol; 2009 Nov; 16(11):855-61. PubMed ID: 19674168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hormone levels during prostaglandin F 2 infusions for therapeutic abortion.
    Speroff L; Caldwell BV; Brock WA; Anderson GG; Hobbins JC
    J Clin Endocrinol Metab; 1972 Mar; 34(3):531-6. PubMed ID: 5011257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of retroperitoneal lymphadenopathy predicts survival of patients with metastatic renal cell carcinoma.
    Vasselli JR; Yang JC; Linehan WM; White DE; Rosenberg SA; Walther MM
    J Urol; 2001 Jul; 166(1):68-72. PubMed ID: 11435825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spontaneous regression of primary and metastatic renal cell carcinoma.
    Edwards MJ; Anderson JA; Angel JR; Harty JI
    J Urol; 1996 Apr; 155(4):1385. PubMed ID: 8632583
    [No Abstract]   [Full Text] [Related]  

  • 19. [Spontaneous regression of lung metastasis of renal cell carcinoma: a case report].
    Yoshino S; Wakui M
    Hinyokika Kiyo; 1988 Dec; 34(12):2167-9. PubMed ID: 3239523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Importance of the detection method for intact dimeric human chorionic gonadotropin without interference with the free human chorionic gonadotropin beta subunit for pregnancy exclusion before liver transplantation in a woman with cholangiocarcinoma.
    Massart C; Lucas C; Rioux-Leclercq N; Fergelot P; Pouvreau-Quillien V; Volatron AC
    Clin Chem Lab Med; 2005; 43(8):886-9. PubMed ID: 16217885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.